Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
143.1 USD | +0.03% | +3.77% | +8.50% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.50% | 14.39B | |
-1.30% | 104B | |
+7.36% | 97.47B | |
+5.71% | 22.25B | |
-12.86% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.70% | 16.36B | |
+39.74% | 12.37B | |
+307.90% | 8.43B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Barclays Raises Neurocrine Biosciences' Price Target to $150 From $145, Maintains Overweight Rating